findmyKOL
Clinical trialNCT04883671RecruitingInterventional

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

SponsorDana-Farber Cancer InstituteEnrollment32Adenoid Cystic CarcinomaMetastatic Adenoid Cystic Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT) will impact the progression of advanced adenoid cystic carcinoma, quality of life, and overall survival. The name(s) of the study intervention involved in this study is: * Stereotactic Body Radiation Therapy (SBRT)
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Francisco

    San Francisco, California, United States

    Sue Yom, MD, PhD
    Recruiting
  • University of Chicago

    Chicago, Illinois, United States

    Alexander T Pearson, MD, PhD
    Recruiting
  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

    Jonathan D Schoenfeld, MD, MPH
    Recruiting
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Jonathan D Schoenfeld, MD, MPH
    Recruiting
  • Md Anderson Cancer Center

    Houston, Texas, United States

    Matthew S Ning, MD, MPH
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Dec 2021
Primary completion
1 Jun 2028
Completion
1 Jun 2030
Last update posted
23 Sept 2025
Registered enrollment
32
Registry id
NCT04883671
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.